Copyright
©The Author(s) 2022.
World J Clin Oncol. Jul 24, 2022; 13(7): 577-586
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.577
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.577
Table 1 Clinicopathological characteristics of the study population
| Characteristic | Group A (ESAS) (n = 100) | Group B (No-ESAS) (n = 100) | P value |
| Age (mean ± SD) | 57.7 ± 11.5 | 56.6 ± 12.4 | 0.524 |
| Age groups, n (%) | 0.880 | ||
| ≤ 60 yr | 64 (64) | 62 (62) | |
| > 60 yr | 36 (36) | 38 (38) | |
| Premenopausal status | 51 (51) | 34 (34) | 0.015 |
| Breast cancer stage, n (%) | |||
| I | 44 (44) | 36 (36) | 0.506 |
| II | 28 (28) | 31 (31) | |
| III | 28 (28) | 33 (33) | |
| Cancer histology, n (%) | |||
| Ductal | 84 (84) | 88 (88) | 0.415 |
| Lobular | 16 (16) | 12 (12) | |
| Tumour size (mean ± SD) , n (%) | 0.258 | ||
| ≤ 2 cm | 52 (52) | 44 (44) | |
| > 2 cm | 48 (48) | 56 (56) | |
| Lymph node status, n (%) | 0.883 | ||
| N0 | 66 (66) | 59 (59) | |
| N+ | 34 (34) | 41 (41) | |
| Himmunohistochemical classification, n (%) | 0.754 | ||
| Luminal A | 12 (12) | 8 (8) | |
| Luminal B | 21 (21) | 25 (25) | |
| HER2 positive | 55 (55) | 54 (54) | |
| TNBC | 12(12) | 13 (13) | |
| Type of surgery, n (%) | 0.157 | ||
| BCS | 58 (58) | 48 (48) | |
| Mastectomy | 42 (42) | 52 (52) |
- Citation: Sanna V, Fedele P, Deiana G, Alicicco MG, Ninniri C, Santoro AN, Pazzola A, Fancellu A. Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer. World J Clin Oncol 2022; 13(7): 577-586
- URL: https://www.wjgnet.com/2218-4333/full/v13/i7/577.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i7.577